Effectivity of oral recombinant DNA vaccine against Streptococcus agalactiae in Nile tilapia. (December 2017)

• Record Type: Journal Article
• Authors: Zhu, Ling; Yang, Qian; Huang, Lingyuan; Wang, Kaiyu; Wang, Xingli; Chen, Defang; Geng, Yi; Huang, Xiaoli; Ouyang, Ping; Lai, Weimin
• Is Part Of: Developmental and comparative immunology. Volume 77(2017)
• Page Start: 77
• Page End: 87
• Publication Date: 2017-12
• Subjects: DNA vaccine -- S. agalactiae -- Immune response -- Nile tilapia; Immunology -- Periodicals; Developmental immunology -- Periodicals; 616.079
• DOI: 10.1016/j.dci.2017.07.024
• Languages: English
• ISSNs: 0145-305X

Abstract

Abstract: The effects of oral vaccination by two immune routes (gavage and mixed fodder administration) using a recombinant DNA vaccine SL7207-pVAX1- sip against Streptococcus agalactiae were assessed. SL7207-pVAX1- sip significantly enhanced various innate immune responses of tilapia, such as total serum protein, superoxide dismutase activity, lysozyme activity, complement C3 concentration in serum, serum antibacterial activity, and interleukin 1β and tumor necrosis factor-α. Vaccinated fish had higher relative percent survival values (57% and 63% for gavage group and mix fodder administration, respectively) at 10 weeks after S. agalactiae infection. When administered mixed fodder, the DNA vaccine SL7207-pVAX1- sip against S. agalactiae may produce more effective protection. These findings can promote the application and development of DNA vaccines in aquaculture. Highlights: Two immune routes of recombinant DNA vaccine SL7207-pVAX1- sip were assessed. Host innate immune responses to vaccine were compared. The vaccine against S. agalactiae with fodder administration can produce more effective protection.